Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Patient Care
Patient Monitoring
Return to: MDBR Home | Patient Care | Patient Monitoring | News
Search Refinements

Patient Monitoring News

View news from other Medical Devices sectors:
31-45 of 840 results
Respicardia raises $58.5m to commercialize remede system for CSA treatment
By MDBR Staff Writer
Medical technology firm Respicardia has raised $58.5 financing to advance the commercialization of remedē system to treat central sleep apnea (CSA).
Patient Care > Patient Monitoring > News
Intersect ENT gets FDA approval for SINUVA sinus implant
Intersect ENT has received approval from the US Food and Drug Administration (FDA) for the SINUVA (mometasone furoate) Sinus Implant, a new targeted approach to treating recurrent nasal polyp disease in patients who have had previous ethmoid sinus surgery.
Patient Care > Patient Monitoring > News
FDA approves Boston Scientific's Vercise deep brain stimulation system
By MDBR Staff Writer
Boston Scientific has secured approval from the US Food and Drug Administration (FDA) for its Vercise deep brain stimulation (DBS) system.
Patient Care > Patient Monitoring > News
Stryker to buy US firm Entellus Medical for $662m
By MDBR Staff Writer
Stryker has signed an agreement to acquire US medical technology firm Entellus Medical for around $662m.
Patient Care > Patient Monitoring > News
LivaNova to buy remaining stake in ImThera Medical for $225m
By MDBR Staff Writer
UK-based medical technology firm LivaNova has agreed to purchase the remaining stake in US firm ImThera Medical for around $225m.
Patient Care > Patient Monitoring > News
Stimwave secures FDA 510(k) clearance for SandShark injectable anchoring system
Stimwave announced the SandShark Injectable Anchor System received the US Food and Drug Administration’s 510(k) clearance.
Patient Care > Patient Monitoring > News
FDA approves first study of Insightec’s Exablate Neuro to open blood-brain barrier in Glioblastoma patients
Insightec has received approval from the US Food and Drug Administration (FDA) to initiate a study to evaluate the safety and feasibility of the Exablate Neuro for disrupting the blood brain barrier (BBB) in patients with Glioblastoma.
Patient Care > Patient Monitoring > News
FDA approves first medical device system to adjust artificial lens after cataract surgery
By MDBR Staff Writer
RxSight has secured approval from the US Food and Drug Administration (FDA) for its light adjustable lens and light delivery device (LDD) to treat patients with pre-existing astigmatism of ≥ 0.75 diopters undergoing cataract surgery.
Patient Care > Patient Monitoring > News
Novocure’s trial shows increased compliance with Optune predicted enhanced survival in glioblastoma patients
Novocure has announced results from a retrospective post-hoc analysis of its phase 3 pivotal EF-14 trial data showing that increased compliance with Optune predicted increased survival in glioblastoma (GBM) patients.
Patient Care > Patient Monitoring > News
Cianna Medical gets FDA nod for wire-free radar breast tumor localization system
By MDBR Staff Writer
Cianna Medical has secured approval from the US Food and Drug Administration (FDA) for its wire-free radar breast tumor localization system.
Patient Care > Patient Monitoring > News
Lensar gets FDA and CE mark for IntelliAxis-L toric IOL alignment guidance
By MDBR Staff Writer
Lensar has secured 510(k) clearance from the US Food and Drug Administration and CE mark approval for IntelliAxis-L, which is an advanced data-driven reference marking capability to guide toric intralocular lens (IOL) alignment.
Patient Care > Patient Monitoring > News
Stryker receives US FDA HDE approval for Neuroform Atlas stent system to treat wide neck aneurysms
Stryker has secured approval from the US Food and Drug Administration for Neuroform Atlas Stent System for marketing under a humanitarian device exemption (HDE).
Patient Care > Patient Monitoring > News
Helius Medical’s PoNS device succeeds in trial of traumatic brain injury
By MDBR Staff Writer
Helius Medical Technologies’ portable neuromodulation stimulator (PoNS) 4.0 device has met primary and secondary effectiveness endpoints in its registrational trial of patients with traumatic brain injury (TBI).
Patient Care > Patient Monitoring > News
Medtronic receives CE mark for world's smallest fully implantable spinal cord stimulator
Medtronic announced that it received CE mark for the Intellis platform for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in the management of certain types of chronic pain.
Patient Care > Patient Monitoring > News
NeuroPace secures funding to commercialise brain-responsive neurostimulation system
By MDBR Staff Writer
US-based medical technology firm NeuroPace has secured $74m of funding to advance the commercialisation of its brain-responsive neurostimulation system to treat epilepsy.
Patient Care > Patient Monitoring > News
31-45 of 840 results